Upstream Bio (UPB) Cash from Financing Activities (2023 - 2026)

Upstream Bio's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $598000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 1858.82% year-over-year to $598000.0; the TTM figure through Mar 2026 stood at $3.1 million (down 99.25% YoY), while the FY2025 annual figure was $2.4 million, down 99.42% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $598000.0, down from $1.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $270.6 million in Q4 2024, with the low at -$1.6 million in Q3 2024.
• The 4-year median for Cash from Financing Activities is $686000.0 (2025), against an average of $42.2 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 203594.74% in 2024, then sank 100.36% in 2025.
• Upstream Bio's Cash from Financing Activities stood at -$133000.0 in 2023, then soared by 203594.74% to $270.6 million in 2024, then slumped by 99.59% to $1.1 million in 2025, then plunged by 45.78% to $598000.0 in 2026.
• Business Quant data shows UPB's Cash from Financing Activities at $598000.0 in Q1 2026, $1.1 million in Q4 2025, and $760000.0 in Q3 2025.